269 related articles for article (PubMed ID: 11899075)
1. Molecular analysis of primary central nervous system and primary intraocular lymphomas.
Tuaillon N; Chan CC
Curr Mol Med; 2001 May; 1(2):259-72. PubMed ID: 11899075
[TBL] [Abstract][Full Text] [Related]
2. Expression of immunoglobulin transcription factors in primary intraocular lymphoma and primary central nervous system lymphoma.
Coupland SE; Loddenkemper C; Smith JR; Braziel RM; Charlotte F; Anagnostopoulos I; Stein H
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):3957-64. PubMed ID: 16249468
[TBL] [Abstract][Full Text] [Related]
3. [Primary intraocular lymphoma].
Coupland SE; Heimann H
Ophthalmologe; 2004 Jan; 101(1):87-98. PubMed ID: 14986704
[TBL] [Abstract][Full Text] [Related]
4. Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO.
Krogh-Jensen M; d'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Ann Oncol; 1994 Apr; 5(4):349-54. PubMed ID: 8075032
[TBL] [Abstract][Full Text] [Related]
5. [Intraocular lymphoma associated with primary malignant lymphoma of the central nervous system: Seven-year experience of a tertiary center].
Joubert R; Bonnin N; Kemeny JL; Moluçon-Chabrot C; Tournilhac O; Bacin F; Chiambaretta F
J Fr Ophtalmol; 2015 Jun; 38(6):559-66. PubMed ID: 25976140
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.
Krogh-Jensen M; D'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Leuk Lymphoma; 1995 Oct; 19(3-4):223-33. PubMed ID: 8535213
[TBL] [Abstract][Full Text] [Related]
7. Mouse models of primary central nervous system lymphomas: tools for basing funding and therapeutic strategies.
Ben Abdelwahed Bagga R; Donnou S; Cosette J; Sautès-Fridman C; Aouni M; Fisson S
J Neurooncol; 2015 Jan; 121(1):9-18. PubMed ID: 25300908
[TBL] [Abstract][Full Text] [Related]
8. Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart.
Chang C; Lin CH; Cheng AL; Medeiros LJ; Chang KC
Histopathology; 2015 Nov; 67(5):625-35. PubMed ID: 25829022
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for intraocular involvement in patients with primary central nervous system lymphoma.
Cho BJ; Yu HG
J Neurooncol; 2014 Dec; 120(3):523-9. PubMed ID: 25119002
[TBL] [Abstract][Full Text] [Related]
10. Primary central nervous system lymphomas--new pathological developments.
Jellinger KA; Paulus W
J Neurooncol; 1995; 24(1):33-6. PubMed ID: 8523072
[TBL] [Abstract][Full Text] [Related]
11. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989.
Miller DC; Hochberg FH; Harris NL; Gruber ML; Louis DN; Cohen H
Cancer; 1994 Aug; 74(4):1383-97. PubMed ID: 8055462
[TBL] [Abstract][Full Text] [Related]
12. Primary intraocular lymphoma.
Sagoo MS; Mehta H; Swampillai AJ; Cohen VM; Amin SZ; Plowman PN; Lightman S
Surv Ophthalmol; 2014; 59(5):503-16. PubMed ID: 24560125
[TBL] [Abstract][Full Text] [Related]
13. Array-based profiling of the lymphoma cell DNA methylome does not unequivocally distinguish primary lymphomas of the central nervous system from non-CNS diffuse large B-cell lymphomas.
Vogt J; Wagener R; Montesinos-Rongen M; Ammerpohl O; Paulus W; Deckert M; Siebert R
Genes Chromosomes Cancer; 2019 Jan; 58(1):66-69. PubMed ID: 30284345
[TBL] [Abstract][Full Text] [Related]
14. Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands.
van der Sanden GA; Schouten LJ; van Dijck JA; van Andel JP; van der Maazen RW; Coebergh JW;
Cancer; 2002 Mar; 94(5):1548-56. PubMed ID: 11920513
[TBL] [Abstract][Full Text] [Related]
15. Eye involvement in primary central nervous system lymphoma.
Farrall AL; Smith JR
Surv Ophthalmol; 2020; 65(5):548-561. PubMed ID: 32057762
[TBL] [Abstract][Full Text] [Related]
16. Intraocular involvement is associated with a high risk of disease relapse in primary central nervous system lymphoma.
Zhuang L; Lai J; Chen K; Ding T; Yuan Y; Ma Y; Kang H; Lin Z; Fan N; Ma J; Zeng Q; Xu X; Wang Q; Chen B
Oncol Rep; 2019 Jan; 41(1):397-404. PubMed ID: 30320386
[TBL] [Abstract][Full Text] [Related]
17. Current concepts in diagnosing and managing primary vitreoretinal (intraocular) lymphoma.
Chan CC; Sen HN
Discov Med; 2013 Feb; 15(81):93-100. PubMed ID: 23449111
[TBL] [Abstract][Full Text] [Related]
18. Primary CNS lymphoma other than DLBCL: a descriptive analysis of clinical features and treatment outcomes.
Lim T; Kim SJ; Kim K; Lee JI; Lim DH; Lee DJ; Baek KK; Lee HY; Han B; Uhm JE; Ko YH; Kim WS
Ann Hematol; 2011 Dec; 90(12):1391-8. PubMed ID: 21479535
[TBL] [Abstract][Full Text] [Related]
19. Intraocular lymphoma: update on diagnosis and management.
Chan CC; Wallace DJ
Cancer Control; 2004; 11(5):285-95. PubMed ID: 15377987
[TBL] [Abstract][Full Text] [Related]
20. Management of primary intraocular lymphoma.
Kim SK; Chan CC; Wallace DJ
Curr Oncol Rep; 2005 Jan; 7(1):74-9. PubMed ID: 15610690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
